Todd Boudreaux

9/2/17
FacebookTwitterEmail
 

EDITORIAL MANAGER

Todd was diagnosed with Type 1 diabetes in 2000, and has been unofficially advocating for T1D ever since. Before joining the team at Beyond Type 1, Todd wrote and produced television shows for Discovery Channel, Travel Channel and Animal Planet. When he’s not in the office, you can usually find him at a baseball game, traveling or drawing on his Etch A Sketch. You can also follow him on instagram @toddboo.

For all editorial inquiries, please contact editor@beyondtype1.org.

News by Todd


Exciting Trial Results for Tandem’s Control-IQ Hybrid Closed Loop System


Participants using Control-IQ saw an increased time in range, lowered HbA1c, and less time in hyperglycemia and hypoglycemia.READ MORE

Preventing Type 1 Diabetes: Results From TrialNet’s Landmark Teplizumab Trial


The immunotherapy drug teplizumab was shown to delay Type 1 diabetes diagnosis a median of 2 years in children and adults at high risk.READ MORE

Tidepool and Medtronic Announce Collaboration on Interoperable Automated Insulin Pump


Tidepool announced that they have partnered with Medtronic to create an interoperable automated insulin pump system.READ MORE

FDA Approves New Treatment for Diabetic Retinopathy


Regeneron Pharmaceuticals announced that the FDA has approved EYLEA (aflibercept) to treat all stages of diabetic retinopathy.READ MORE

Express Scripts Won’t Cover Lilly’s Generic Insulin


The largest PBM in the U.S. recently released a list of formulary exclusions that included 'Insulin Lispro' as an excluded medication. READ MORE

DIY Loop Now Compatible with Omnipod


Loop announced that a testing branch of their DIY Loop is now compatible with the current 'Eros' generation of Omnipod, and available to the public.READ MORE

Insulin Manufacturers and PBMs Testify Before Congress


The hearing was contentious throughout, with House members grilling both the manufacturers and the PBM representatives about the reasons for high costs.READ MORE

First Oral Medication to Treat T1D Approved in Europe


The European Commission (EC) has approved the use of Forxiga (dapagliflozin) as an add-on treatment to insulin therapy for use in in patients with T1D who have a BMI ≥ 27 kg/m2READ MORE

Pharma Execs Testify Before Senate on High Drug Prices


Executives from pharmaceutical companies were called on to testify before the Senate Finance Committee to explain the soaring cost of prescription drug prices in the U.S.READ MORE

Insulin Manufacturers Called on to Explain Skyrocketing Prices


On Tuesday, a group of U.S. Senators led by Patty Murray (D-WA) sent letters to executives at Eli Lilly, Novo Nordisk, and Sanofi demanding information about the rising prices of insulin.  READ MORE

Government Shutdown Leads to Insulin Rationing


Government workers are increasingly unable to afford basic necessities like food, power, and critical medications like insulin.READ MORE

Diabetes Patients Are Being Denied Access to Life-Changing Technology


A recent survey conducted by Dexcom and Beyond Type 1 has revealed that many people with Type 1 diabetes are unaware of continuous glucose monitoring.READ MORE

Research Shows Fridges Might Be Destroying Insulin


A 16-month study has shown that 79% of insulin is kept at temperatures outside of the recommended range. Insulin stored in the fridge is at a much higher risk. READ MORE

Interviews by Todd

Country Music Star Eric Paslay Talks Life With T1D


Beyond Type 1 recently spoke with Eric Paslay about life with diabetes, the importance of role models, and what he hopes to accomplish with his new podcast.READ MORE

Actress Jennifer Bartels on Embracing Life with T1D


Beyond Type 1 recently talked to actress Jennifer Bartels about her diagnosis, how she is bringing awareness to T1D, and her plans for the future.READ MORE

JDRF’s New CEO Aaron Kowalski Talks to Beyond Type 1


Beyond Type 1 spoke with newly-appointed JDRF CEO Aaron Kowalski about his priorities, the future of T1D research and treatment options, and how his diabetes has informed his work. READ MORE

The Future of Glucagon with Xeris CEO Paul Edick


Beyond Type 1 talks to Paul Edick, President and CEO of Xeris Pharmaceuticals, about their revolutionary glucagon pen.READ MORE

1 on 1 with Soccer Star Maxim Speed


Maxim Speed is an online sensation who certainly lives up to his name. The 12-year-old from Oahu, Hawaii has been playing soccer practically from the time he could walk. Max recently spoke with Beyond Type 1 about his diagnosis, what it’s like playing soccer with T1D, and his plans for the future.READ MORE

Hiking the Appalachian Trail with T1D


When Rachel Hemond set out on her 21st birthday to hike the Appalachian Trail, it was the culmination of a life full of adventure and exploration.READ MORE

Introducing Francine Kaufman: Newest Member of Science Advisory Council


Meet Francine Kaufman M.D., the newest member of the Beyond Type 1 Science Advisory Council! Dr. Kaufman recently spoke with Beyond Type 1 about her history of treating diabetes, her work abroad, the global diabetes landscape, and the future of T1D.READ MORE

Caitlin Kinnunen: Type 1 on Broadway


Caitlin Kinnunen opens up about The Prom, how she manages her diabetes on stage, the importance of having a strong support system, and her aspirations for the future. READ MORE

Runner Spotlight: Gary and Katrina Pilkington


Health and fitness are a priority in Gary and Katrina's lives so that they can set an example for their daughter and inspire others to do the same!READ MORE

Runner Spotlight: Patrick Votruba


Beyond Type Run Marathoner Patrick Votruba talks about his diagnosis, experience running in ultra marathons, and how he has been training for the 2018 NYC Marathon.READ MORE

Runner Spotlight: Léonor Marchand


Léonor Marchand talks with Beyond Type 1 about her running inspiration, how she's preparing for the NYC Marathon, and advice for people living with Type 1 diabetes.READ MORE